tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Compare Kymera Therapeutics (KYMR) vs. Competitors

Compare
404 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$81.32
$6.42B
-22.61
104.35%
21 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$87.93
$5.55B
140.16
128.33%
12 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$25.17
$3.16B
84.10
-21.10%
9 Buy
6 Hold
0 Sell
Moderate Buy
Crinetics Pharmaceuticals
$47.52
$4.55B
-10.58
-6.22%
9 Buy
1 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$13.83
$987.10M
-4.16
-74.17%
8 Buy
3 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
80.35
41.03
104.35%
PTGX
Protagonist Therapeutics
87.93
49.42
128.33%
APLS
Apellis Pharmaceuticals
25.17
-6.73
-21.10%
CRNX
Crinetics Pharmaceuticals
47.52
-3.15
-6.22%
AKRO
MLTX
MoonLake Immunotherapeutics
13.70
-39.32
-74.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts